SGMO
Sangamo Therapeutics IncNASDAQ
Healthcare • Biotechnology
Updated 8 days ago
Coverage limited
$0.070.00%
Close Jun 30, 2026
- Market cap
- $28.83M
- 1 month
- -66.4%
- 3 months
- -76.1%
- 1 year
- -86.3%
- 52-week range
- $0.07$0.74
- Dividend
- No dividends on record
Fundamentals · trailing 12 months to Mar 31, 2026
- Revenue
- $34.56M
- Net income
- -$123.33M
- Free cash flow
- -$90.46M
- Book value
- $26.34K
- Total debt
- —
- P/E
- —
- Price / sales
- 0.8×
- Price / book
- 1,094.5×
- FCF yield
- -313.7%
- Net margin
- -356.9%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if SGMO is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: HIGH
2 top institutions tracked
as of 2026-Q2 (filed 2026-09-23)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
5 filers reported a long position in SGMO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $22K | 400K | Unchanged |
| SIMPLEX TRADING, LLC | $4.1K | 76.5K | New |
| Axiom Investment Management LLC | $1.4K | 25.4K | Unchanged |
| FLOW TRADERS U.S. LLC | $1K | 21.5K | +0.2% |
| Heritage Investment Group, Inc. | $539 | 10K | New |
Get the Full Analysis for SGMO
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.